Nanotechnology and Tissue Engineering: Building the Future of Regenerative Medicine

S. Vanitha, Vamika Anil and S. Prerna

Chapter 24 in Convergence of Technology & Biology ─ Transforming Life Sciences, 2025, pp 263-270 from Shanlax Publications

Abstract: Nanotechnology offers groundbreaking methods for medical diagnosis, treatment, tissue regeneration, and biomedical imaging. The small size of nanoparticles (1-100 nanometers) facilitates interaction with biological systems, improving the sensitivity and specificity of disease detection through enhanced imaging. Nanotechnology reshapes dentistry, improving diagnostics, treatment precision, and dental materials. Developing nanocomposites, nano-adhesives, and nano-bone grafts represents a significant advancement in dental materials. Nanorobots offer the potential for pain-free procedures and targeted drug delivery within the oral cavity. Nanostructured scaffolds used in tissue engineering mimic the extracellular matrix. It promotes cell growth and tissue regeneration. This technology plays a key role in improving the effective monitoring of bioelectric signals in cancer treatment using advanced sensors and electrodes. It revolutionizes surgery by enabling high-precision, minimally invasive procedures through nanorobotic technology. Organ-on-a-chip (OoC) systems offer an innovative and versatile micro-physiological platform for replicating the dynamic tissue microenvironment, enabling the study of nanotechnology-biology interactions. Researchers are using models that combine nanotechnology, microfluidics, and tissue engineering to mimic the complex dynamics of musculoskeletal tissues in a controlled manner. This allows them to effectively study disease mechanisms and assess therapeutic approaches, such as nanotechnology-based interventions. Scientists are leveraging the integration of nanotechnology with other technologies like tissue engineering to achieve targeted drug delivery, precise sensing, and versatile manipulation of cellular processes, driving a paradigm shift in research at the cellular level and early disease diagnosis and possible prognosis. Nevertheless, resolving safety and bioaccumulation issues is a prerequisite for its broader clinical translation.

Date: 2025
ISBN: 978-93-6163-763-6
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.shanlaxpublications.com/p/ctbtls/ch024.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dax:ctbtls:978-93-6163-763-6:p:263-270

Access Statistics for this chapter

More chapters in Convergence of Technology & Biology ─ Transforming Life Sciences from Shanlax Publications Madurai, Tamil Nadu, India.
Bibliographic data for series maintained by S.Lakshmanan ().